Prime Aesthetics Clinic Ltd 10451638 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of the provision of beauty treatments. Digita Accounts Production Advanced 6.30.9574.0 true true 10451638 2023-04-01 2024-03-31 10451638 2024-03-31 10451638 core:CurrentFinancialInstruments 2024-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10451638 core:Non-currentFinancialInstruments 2024-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 10451638 core:MoreThanFiveYears 1 2024-03-31 10451638 core:FurnitureFittingsToolsEquipment 2024-03-31 10451638 core:OtherPropertyPlantEquipment 2024-03-31 10451638 bus:SmallEntities 2023-04-01 2024-03-31 10451638 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10451638 bus:FilletedAccounts 2023-04-01 2024-03-31 10451638 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10451638 bus:RegisteredOffice 2023-04-01 2024-03-31 10451638 bus:Director1 2023-04-01 2024-03-31 10451638 bus:Director2 2023-04-01 2024-03-31 10451638 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10451638 core:FurnitureFittings 2023-04-01 2024-03-31 10451638 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 10451638 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 10451638 core:PlantMachinery 2023-04-01 2024-03-31 10451638 countries:EnglandWales 2023-04-01 2024-03-31 10451638 2023-03-31 10451638 core:FurnitureFittingsToolsEquipment 2023-03-31 10451638 core:OtherPropertyPlantEquipment 2023-03-31 10451638 2022-04-01 2023-03-31 10451638 2023-03-31 10451638 core:CurrentFinancialInstruments 2023-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear core:PreviouslyStatedAmount 2023-03-31 10451638 core:Non-currentFinancialInstruments 2023-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear core:PreviouslyStatedAmount 2023-03-31 10451638 core:MoreThanFiveYears 1 2023-03-31 10451638 core:FurnitureFittingsToolsEquipment 2023-03-31 10451638 core:OtherPropertyPlantEquipment 2023-03-31 10451638 core:PreviouslyStatedAmount 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 10451638

Prime Aesthetics Clinic Ltd

Unaudited Financial Statements

for the Year Ended 31 March 2024

Brebners
Chartered Accountants
Brebners
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

 

Prime Aesthetics Clinic Ltd

Statement of Financial Position as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

30,201

29,206

Current assets

 

Stocks

5

37,528

22,382

Debtors

6

15,598

1,813

Cash at bank and in hand

 

47,753

1,045

 

100,879

25,240

Creditors: Amounts falling due within one year

7

(35,602)

(193,608)

Net current assets/(liabilities)

 

65,277

(168,368)

Total assets less current liabilities

 

95,478

(139,162)

Creditors: Amounts falling due after more than one year

7

(195,011)

(13,473)

Net liabilities

 

(99,533)

(152,635)

Capital and reserves

 

Called up share capital

1

1

Retained earnings

(99,534)

(152,636)

Shareholders' deficit

 

(99,533)

(152,635)

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Statement of Income and Retained Earnings has been taken.

 

Prime Aesthetics Clinic Ltd

Statement of Financial Position as at 31 March 2024

Approved and authorised by the Board on 19 November 2024 and signed on its behalf by:
 

.........................................

Mr T Salahi

Director

.........................................

Mrs F Salahi

Director

Company registration number: 10451638

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Brebners
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

The principal activity of the company is that of the provision of beauty treatments.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except any items disclosed in the accounting policies as being shown at fair value and are presented in sterling, which is the functional currency of the entity.

Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Going concern

The company made a profit for the year ended 31 March 2024 and had net current liabilities at that date amounting to £65,277. The directors have confirmed they will continue to support the company until such time as the company has sufficient working capital.

Having made enquiries the directors have reasonable expectation that the company has adequate resources to remain in operational existence for the foreseeable future. Accordingly, the directors continue to prepare the financial statements on the going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

The company recognises revenue at the point that the beauty treatments are provided.

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture and fixtures

20% straight line

Medical equipment

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the income statement over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company during the year was 2 (2023 - 2).

4

Tangible assets

Furniture and fixtures
£

Medical equipment
£

Total
£

Cost or valuation

At 1 April 2023

50,802

14,798

65,600

Additions

1,743

7,231

8,974

At 31 March 2024

52,545

22,029

74,574

Depreciation

At 1 April 2023

28,527

7,867

36,394

Charge for the year

5,864

2,115

7,979

At 31 March 2024

34,391

9,982

44,373

Carrying amount

At 31 March 2024

18,154

12,047

30,201

At 31 March 2023

22,275

6,931

29,206

5

Stocks

2024
£

2023
£

Stock

37,528

22,382

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

6

Debtors

2024
£

2023
£

Trade debtors

3,244

1,813

Other debtors

12,354

-

15,598

1,813

7

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Bank loans and overdrafts

8

11,617

32,082

Taxation and social security

 

14,195

8,173

Other creditors

 

9,790

153,353

 

35,602

193,608

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Loans and borrowings

8

195,011

13,473

2024
£

2023
£

Due after more than five years

After more than five years by instalments

161,082

-

-

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

8

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Bank borrowings

11,617

5,971

Other borrowings

-

26,111

11,617

32,082

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

195,011

13,473

9

Transactions with directors

At 31 March 2024 an amount of £12,354 (2023: £Nil) was due from the directors. During the year there were advances of £15,054 and repayments of £2,700. No interest has been charged and there are no terms in place.